Japan Physician Groups' Controversial Push For Xocova Backfires

A controversial letter from two Japanese doctors' associations seemingly pressing regulators to approve Shionogi’s oral COVID-19 drug prompts a backlash from other physicians. 

Several Japanese Doctors Openly Rejected the idea Of approving Xocova without proving efficacy
Several Japanese Doctors Openly Rejected the idea Of approving Xocova without proving efficacy • Source: Shutterstock

Japan has been encouraging domestic pharmaceutical firms to develop vaccines and therapeutic drugs to tackle COVID-19.

However, a number of recent online posts by Japanese physicians over Shionogi & Co. Ltd.’s oral antiviral candidate Xocova...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia